Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hengkang Liu"'
Autor:
Delin Ma, Pengcheng Wei, Hengkang Liu, Jialing Hao, Zhuomiaoyu Chen, Yingming Chu, Zuyin Li, Wenzai Shi, Zhigao Yuan, Qian Cheng, Jie Gao, Jiye Zhu, Zhao Li
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-24 (2024)
Abstract Background Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor with a poor prognosis, predominantly CA19-9 positive. High CA19-9 levels correlate with increased aggressiveness and worse outcomes. This study employs multi-omics analysi
Externí odkaz:
https://doaj.org/article/9182513c37874f52bdacdf3f8d815961
Autor:
Xiao Xiang, Ziyang Liu, Chong Zhang, Zhao Li, Jie Gao, Changkun Zhang, Qi Cao, Jinghui Cheng, Hengkang Liu, Dingbao Chen, Qian Cheng, Ning Zhang, Ruidong Xue, Fan Bai, Jiye Zhu
Publikováno v:
Advanced Science, Vol 8, Iss 17, Pp n/a-n/a (2021)
Abstract Intrahepatic cholangiocarcinoma (ICC) is highly heterogeneous. Here, the authors perform exome sequencing and bulk RNA sequencing on 73 tumor regions from 14 ICC patients to portray the multi‐faceted intratumor heterogeneity (ITH) landscap
Externí odkaz:
https://doaj.org/article/4b70af9a35b2413cbacc820ac9342bc4
Autor:
Ruidong Xue, Qiming Zhang, Qi Cao, Ruirui Kong, Xiao Xiang, Hengkang Liu, Mei Feng, Fangyanni Wang, Jinghui Cheng, Zhao Li, Qimin Zhan, Mi Deng, Jiye Zhu, Zemin Zhang, Ning Zhang
Publikováno v:
Nature. 612:141-147
The heterogeneity of the tumour immune microenvironment (TIME), organized by various immune and stromal cells, is a major contributing factor of tumour metastasis, relapse and drug resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b58955985a81f11b7af64acf9e67fb34
https://doi.org/10.1038/s41586-022-05400-x
https://doi.org/10.1038/s41586-022-05400-x
Autor:
Rong Liu, Mei Feng, Ruibing Chen, Xianshu Gao, Hui Yang, Yucun Liu, Ruirui Kong, Ning Zhang, Hengkang Liu, Xin Dong, Hua Guo
Publikováno v:
International Journal of Biological Sciences
As one of the most ominous malignancies, hepatocellular carcinoma (HCC) is frequently diagnosed at an advanced stage, owing to its aggressive invasion and metastatic spread. Emerging evidence has demonstrated that Rictor, as a unique component of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0143a2a046498e837b9443563019a975
https://pubmed.ncbi.nlm.nih.gov/33061800
https://pubmed.ncbi.nlm.nih.gov/33061800
Autor:
Jinghui Cheng, Hengkang Liu, Ning Zhang, Xiao Xiang, Ruidong Xue, Fan Bai, Ji-ye Zhu, Ziyang Liu, Qian Cheng, Zhao Li, Dingbao Chen, Jie Gao, Changkun Zhang, Qi Cao, Chong Zhang
Publikováno v:
Advanced Science, Vol 8, Iss 17, Pp n/a-n/a (2021)
Advanced Science
Advanced Science
Intrahepatic cholangiocarcinoma (ICC) is highly heterogeneous. Here, the authors perform exome sequencing and bulk RNA sequencing on 73 tumor regions from 14 ICC patients to portray the multi‐faceted intratumor heterogeneity (ITH) landscape of ICC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f25d5c4b7926d79a09330357782ee754
https://doi.org/10.1002/advs.202101230
https://doi.org/10.1002/advs.202101230